Antônio Barbieri

5.3k citations
122 papers · 3.8k · 1 hit paper · h-index 38

Impact in

    • Curcumin's Biomedical Applications
  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Chemokine receptors and signaling

Papers in

    • Peptidase Inhibition and Analysis 9
    • Chemokine receptors and signaling 7
    • Cancer Immunotherapy and Biomarkers 6

Antônio Barbieri

118 papers receiving 3.7k citations

Antônio Barbieri's Hit Papers

The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin 2021 · 280 citations
2800+1+3Years since publication50100150200250

Peers

Antônio Barbieri
Comparison fields: 5 of 131
  • Molecular Medicine 191
  • Oncology 806
  • Cancer Research 400
  • Complementary and alternative medicine 170
  • Psychiatry and Mental health 257
Replace Yoshinobu Hirose with:
Yoshinobu Hirose Japan
Li Lin China
Roberto Bei Italy
Hong Cai China
Fuu‐Jen Tsai Taiwan
Yong Yang China
Yang Li China
Nasser Hashemi Goradel Iran
Yong‐Yeon Cho South Korea
Yi Chen China
Antônio Barbieri relative to Yoshinobu Hirose Japan Yoshinobu Hirose's profile →
Citations per field
00.5×3.1×
Yoshinobu Hirose · 1×
Citations per year

Countries citing papers authored by Antônio Barbieri

Since Specialization
Citations

This map shows the geographic impact of Antônio Barbieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antônio Barbieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antônio Barbieri more than expected).

Fields of papers citing papers by Antônio Barbieri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antônio Barbieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antônio Barbieri. The network helps show where Antônio Barbieri may publish in the future.

Co-authors

The 25 scholars most cited alongside Antônio Barbieri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Antônio Barbieri Line = papers co-authored together Antônio Barbieri links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The SGLT-2 inhibitor empagliflozin improves myocardial strain, reduces cardiac fibrosis and pro-inflammatory cytokines in non-diabetic mice treated with doxorubicin
Hit paper breakdown →
2021280
2 2018165
3 2018153
4 2016112
5 2017110
6 201597
7 201395
8 201389
9 200787
10 201985
11 201579
12 201376
13 201573
14 200870
15 200170
16 201867
17 200360
18 202058
19 201755
20 201453

About Antônio Barbieri

Antônio Barbieri is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Psychiatry and Mental health and Immunology, having authored 122 papers that have together received 3.8k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Cancer, Stress, Anesthesia, and Immune Response (10 papers), Peptidase Inhibition and Analysis (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (8 papers), Chemokine receptors and signaling (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers) and Neuropeptides and Animal Physiology (5 papers). The work is most often cited by research in Molecular Medicine (191 citations), Oncology (806 citations), Cancer Research (400 citations), Complementary and alternative medicine (170 citations) and Psychiatry and Mental health (257 citations). Antônio Barbieri has collaborated with scholars based in Italy, United States and Brazil. Frequent co-authors include Claudio Arra, Giuseppe Palma, Domenica Rea, Sabrina Bimonte, Antonio Luciano, Nicola Maurea, Gerardo Botti, Vincenzo Quagliariello, Arturo Cuomo and Vitale Del Vecchio. Their work appears in journals such as BioMed Research International, Oncotarget, Cell Death and Disease, OncoTargets and Therapy and Nutrients.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact